The immunosuppressants kits market is projected to grow from USD 1,340.4 million in 2026 to USD 2,920.7 million by 2036, at a CAGR of 8.1%. Tacrolimus TDM kits will dominate with a 24.0% market share, while kidney transplant monitoring will lead the applications segment with a 32.0% share.